Blacks experience morbidity and mortality earlier in the life course compared to whites. Such premature declines in health may be indicative of an acceleration of the aging process. The current study uses data on 7644 black and white participants, ages 30 and above, from the third National Health and Nutrition Examination Survey, to compare the biological ages of blacks and whites as indicated from a combination of ten biomarkers and to determine if such differences in biological age relative to chronological age account for racial disparities in mortality. At a specified chronological age, blacks are approximately 3 years older biologically than whites. Differences in biological age between blacks and whites appear to increase up until ages 60e65 and then decline, presumably due to mortality selection. Finally, differences in biological age were found to completely account for higher levels of all-cause, cardiovascular and cancer mortality among blacks. Overall, these results suggest that being black is associated with significantly higher biological age at a given chronological age and that this is a pathway to early death both overall and from the major age-related diseases.
Introduction
Race is linked to striking health disparities in the United States. Overall, blacks experience death and disease much earlier in the life course than do whites, which may suggest that on average blacks are aging faster (Hayward et al., 2000) . Because the progression of physiological deterioration that accompanies aging may be strongly related to environmental factors (Finch and Tanzi, 1997) , it is conceivable that the various social, economic, mental, and physical factors encountered by many racial minorities throughout their lives may be capable of causing an acceleration of the aging process.
A number of factors have been shown to contribute to racial differences in morbidity and mortality: socioeconomic status (SES) (Hayward et al., 2000; Franks et al., 2006) , neighborhood (Williams and Collins, 2001; Acevedo-Garcia et al., 2008) , availability of quality healthcare (Mayberry et al., 2000; National Healthcare Disparities Report, 2009 ), behaviors (Jackson et al., 2010) , and psychological stress (McEwen, 1998) . Over time, these factors have the ability to get "under the skin" and alter physiological functioning (Taylor et al., 1997; Kuzawa and Sweet, 2009) . Blacks also experience more discrimination, have less economic security and often live in worse neighborhoods, offering fewer nutritional options, worse air quality, and less access to recreational activities (Krieger et al., 1993; Ellen et al., 2001; Bell and Ebisu, 2012) . These experiences may lead to higher levels of both physical and psychological stress with the potential to cause a myriad of biological changes with implications for aging. Finally, the higher prevalence of dangerous health behaviors, such as obesity, among blacks relative to whites (Flegal et al., 2012) , are also believed to contribute to progressive breakdowns in biological tissues and systems, leading to widening gaps in physiological function. Growing disparity in physiological functioning due to the continual exposure to adverse conditions is the premise of the "Weathering Hypothesis", which suggests that the negative effects of exposure to hazardous physical, social, and economic environments of socially disadvantaged racial groups accumulate over the lifespan and contribute to premature health deterioration, which may be indicative of an acceleration of the biological aging process (Geronimus et al., 2006) .
The pace of age-related deterioration, potentially resulting from the accumulation of tissue and cellular damage to molecules like DNA and proteins, may be strongly influenced by the amount of wear and tear the body undergoes over time (Selye and Tuchweber, 1976) . As a result, individuals exposed to hazardous environments may presumably age quicker, causing them to appear biologically older at a given chronological age. In fact, previous research examining race differences in cumulative biological risk have shown that on average, blacks have the same number of "high-risk" (indicated using clinically established cutoffs) physiological indicators as whites who are significantly older chronologically (Geronimus et al., 2006; Crimmins et al., 2007) .
The earlier onset of aging-related deteriorations in physiological functioning is believed to also give rise to premature incidence of mortality. It has been reported that life expectancy for blacks is about 5 years less than whites (Arias, 2007) and contributes to approximately 100,000 excess deaths per year (Levine et al., 2001) . Additionally, dramatic racial disadvantages have been found across multiple domains of health. Even in middle-age, blacks have been shown to have significantly higher prevalence of both fatal and non-fatal chronic conditions than whites (Hayward et al., 2000) and being black is often associated with earlier onset of many agerelated chronic diseases (Bibbins-Domingo et al., 2009 ). This shift in the age curvedin which the onset of death and disease occurs earlier in lifedis thought to explain why racial disparities in mortality risks cross-over in late life, resulting from mortality selection at earlier ages (Johnson, 2000; Manton et al., 1979) . Taken together, this may suggest that a majority of those in the black population may be aging faster than the white population in the U.S.
Biological age measures were developed to quantify multisystem age-related changes on a physiological level and may be useful as proxies for the pace or extent of aging of an individual. While the concept of combining multiple measures into a single variable to model the rate of aging was proposed over fifty years ago, recent techniques have been found to be promising predictors of aging-related health outcomes (Cho et al., 2010; Levine, 2013) . These measures utilize information from multiple biomarkers to determine where an individual lies on an aging trajectory. Typically, the trajectory is determined using a data driven approach that calculates age-associated differences in the various markers within a large representative sample (Bae et al., 2008; Krøll and Saxtrup, 2000; Nakamura and Miyao, 2007) . As a result, biological age reflects the chronological age which on average is characterized by the specified biological profile. For example, someone with a biological age of 50 has the physiological functioning of the average 50 year old within the population. An individual's chronological age can be subtracted from biological age to determine whether the pace of aging for an individual or group is accelerated (i.e. they are older biologically than they are chronologically). For this reason, although it is not an actual marker of mortality risk, the concept of biological age may be useful for examining health disparities, as it allows us to directly estimate the degree of aging, or the difference between biological and chronological age, of disadvantaged groups, as well as compare biological age for race groups at varying chronological ages.
Using data from the National Health and Nutrition Examination Survey (NHANES III), this study examines 1) the racial difference in the pace of aging across ages and by ten-year age groups, to determine if blacks are aging biologically faster than whites and whether disparities in the pace of aging decline or cross-over in later life; and 2) whether these differences in the pace of aging, account for racial disparities in age-specific risks of all-cause mortality, cardiovascular disease (CVD) mortality, and cancer mortality. Overall, we hypothesize that blacks will have higher levels of accelerated aging compared to whites. However, these differences should decrease with age since the most disadvantaged are selected out of the population earlier. Finally, we hypothesize that racial differences in pace of aging will account for the higher mortality risk among blacks.
Materials and methods

Study population
We use data from NHANES III, a nationally representative, crosssectional study conducted by the National Center for Health Statistics (NCHS) between 1988 and 1994. Data were collected from at-home interviews and examinations taking place at a Mobile Examination Center (MEC). Further details of recruitment, procedures, population characteristics and study design are available through the Centers for Disease Control and Prevention (U.S. Department of Health and Human Services, 2001) . Our analytic sample (N ¼ 7587) was restricted to black and white subjects ages 30e89. Hispanics were excluded because, although they have slightly higher life expectancy than whites, nativity is believed to be may be a major factor in this observation, and there is evidence that these differences may be explained by the "salmon hypothesis" which suggests that many Hispanics may return to their country of origin once they become ill and thus their mortality is not observed (Crimmins et al.) . Those over age 89 were excluded given that NHANES III top-codes age at 90. Complete biomarker data was available for approximately 70% of the age-eligible sample. However, excluded subjects were more likely to be black, have lower education, were older, and were more likely to die between baseline and follow-up.
Biological age measure
Our estimation was calculated using information for ten bio-markersdC-Reactive Protein (CRP), Serum Creatinine, Glycosylated Hemoglobin (HbA1c), Systolic Blood Pressure, Serum Albumin, Total Cholesterol, Cytomegalovirus Optical Density (CMV), Serum Alkaline Phosphatase, Forced Expiratory Volume at 1 s (FEV1), and Serum Urea Nitrogen. These markers were selected because they had been suggested as potential biomarkers of aging, used in prior estimations of Biological Age using the NHANES III sample (Levine, 2013) , or had been found to significantly correlate with chronological age at r > 0.10. Together, these biomarkers provide an indication of metabolic, cardiovascular, inflammatory, kidney, liver, and lung functioning.
Biological age was calculated in accordance with the method proposed by Klemera and Doubal (2006) . This method has been shown to predict death more accurately than other well-known Biological Age algorithms, such as Multiple Linear Regression and Principle Component Analysis, and was found to be a better indicator of mortality risk than chronological age (Levine, 2013) . The estimated Biological Age calculation combines information from m ¼ 10 regression lines of the m ¼ 10 biomarker indicators regressed on chronological age (Eq. (1)).
In Equation (1), k j and q j are the slope and intercept, respectively, for each biomarker regressed on chronological age, x j is the participant's measured value for a given biomarker, s j is the root mean squared error of a biomarker regressed on chronological age, and CA represents chronological age. Additionally, s 2 BA is the variance of the random variable, R BA , which represents the difference between participants' biological and chronological age.
Sociodemographic characteristics
Chronological age, race, sex, education, and smoking were based on self-reports. Subjects were categorized into two race groupsdNon-Hispanic white and Non-Hispanic Black. Education was used as an indicator of SES. Reported school years completed were used to create four education groups: <12 years (less than a high school education), 12 years (high school degree), 13e15 years (some college), and 16þ years (college degree). Next, three smoking groups were created based on subjects' answers to two questions: non-smokers (reported not having smoked at least 100 cigarettes during their life time), former-smokers (not currently smoking but reported having smoked at least 100 cigarettes during their life time), and current smokers. Finally, BMI was calculated as measured weight (in kg) divided by measured height (in meters) squared, and used to classify participants as underweight (BMI<18.5), normal weight (BMI 18.5e24.9), overweight (BMI 25e29.9), and obese (BMI 30þ).
Mortality
Mortality follow-up and person-months of follow-up were available for all participants from linked records from the National Death Index through 2006 (U.S. Department of Health and Human Services, 2001). Information was provided for 113 potential underlying causes of death (UCOD-113), and used to code for all-cause mortality, cardiovascular disease (CVD) mortality, and cancer mortality. For all mortality analyses, violent, accidental or HIV related deaths were censored given that our study is concerned with age-related mortality that can be linked to chronic diseases.
Statistical analysis
Using OLS regression, we compared the biological ages of blacks and whites adjusting for chronological age and sex, and then again after adjusting for chronological age, sex, and additional covariates such as education, BMI and smoking. Results from these models were then used to estimate adjusted mean biological age for the two groups. Biological ages of blacks and whites were then compared in ten-year age groups to determine whether differences converged later in life. Finally we examined whether Biological Age could explain racial disparities in mortality using Cox Proportional Hazard Models. First, models were run only controlling for chronological age and sex to determine the association between race and mortality (baseline models). Next we reran models, adjusting for biological age to determine whether it mediated the association between race and mortality and then reran these models with the inclusion of covariates such as education, BMI and smoking. We also examined whether covariates such as alcohol consumption, physical activity, and prevalence of CVD, cancer, COPD, and diabetes influenced our results. Overall, we found that they had no significant influence on our results (not shown), and as a result we did not include them in our final models given that they contributed to more participants being excluded due to missingness. Causespecific mortality was examined using a competing-risks framework. All analyses were run in STATA and used sample weights and appropriate survey procedures for dealing for complex sampling design.
Results
Sample description
As shown in Table 1 , both chronological and biological age had means of 50.2 years; however, as expected the standard deviation was slightly larger for biological age (15.5) than chronological age (14.9). The sample is mostly made up of whites, with only about 11% blacks. Approximately 10% of the sample never attended high school, one-quarter attended but did not graduate from high school, one-third completed high school, one-fifth had some college education, and one-quarter completed at least four years of college. Just over half of the subjects are female (53%). Overall, the majority of subjects had a normal BMI (38.6%), while 35.1% were overweight, 24.5% were obese, and approximately 2% were underweight. Over half the sample has a history of smoking, with 31% reporting they were former smokers, and 28% reporting that they were current smokers. Finally, over the 18-year follow-up, 20% of subjects died overall, 9% died from CVD, and 5.5% died from cancer. The analysis is based on a total of 97,557 person-years of exposure for 7587 subjects.
Biological age by race
Adjusted means for Biological Age by race are shown in Table 2 . When controlling for chronological age and sex, blacks were found to have biological ages that were significantly higher than whites (P < .001). On average, the biological age for blacks was 53.16 years, which was more than a 3 year increase over whites, who had an average biological age of 49.84 years. Next, in addition to controlling for chronological age and sex, means were also adjusted for SES (as measured by years of education), BMI, and smoking, to determine if these accounted for the difference in biological age between blacks and whites. Results showed that even when controlling for SES and health behaviors, blacks were still found to have higher biological ages than whites (P < .001). Nevertheless, the difference was slightly reduced (2.83 years), with blacks having a mean of 52.72 years compared to 49.89 years for whites. Overall, this suggests that on average blacks have the physiological functioning of whites who are more than three years older chronologically. Furthermore, even when accounting for the effects of SES, obesity, and smoking, some of the differences were attenuated; however, with chronological age, SES and health behaviors controlled blacks are still biologically older than whites.
To test whether differences in biological age by race varied across the age range, we compared adjusted means for Biological Age by race within ten year age groups (controlling for chronological age and sex). As shown in Fig. 1 , differences in biological age between blacks and whites increased up until ages 60e69dwhen blacks were found to be 4.82 years older biologically than whites (P < .001). However, after ages 60e69 the difference in biological age between black and whites steadily declined until there was only a 1.17 year difference (P ¼ .054) for those 80e89 years old.
The mortality associated with accelerated or decelerated biological aging
Cox proportional hazard models, controlling for chronological age and sex, were run to determine the overall mortality and disease-specific mortality risks associated with being black. As shown in Table 3 , subjects who are black were 46% more likely to die overall (HR: 1.46, 95%CI: 1.30e1.65), 40% more likely to die from CVD (HR: 1.40, 95%CI: 1.18e1.67), and 51% more likely to die from cancer (HR: 1.51, 95%CI: 1.24e1.85) when compared to subjects who are white. Additionally, a one year increase in chronological age was associated with an 11% increase in all-cause mortality (HR: 1.11, 95%CI: 1.10e1.11), a 12% increase in CVD mortality (HR: 1.12, 95%CI: 1.11e1.13), and an 8% increase in cancer mortality (HR: 1.08, 95%CI: 1.07e1.09). This suggests that the increased risk of mortality associated with being black is equivalent to the risks associated with a 3e6 year increase in chronological age.
When models were run controlling for biological age, it completely accounted for racial disparities in all-cause, CVD, and cancer mortality. While a one year increase in biological age was associated with having an 11% greater risk for all-cause mortality (HR: 1.11, 95%CI: 1.09e1.12), being black no longer significantly increased the risk of all-cause mortality (HR: 0.97, 95%CI: 0.85e1.11). Similarly, being one year older biologically was associated with an 11% increase in the risk of CVD mortality (HR: 1.11, 95% CI: 1.10e1.13) and a 6% increase in the risk of cancer mortality (HR: 1.06, 95%CI: 1.04e1.08); however, there were no longer significant differences in the risk of either CVD or cancer mortality risks for blacks relative to whites (HR CVD : 0.91, 95%CI: 0.75e1.1; HR Cancer : 1.20, 95%CI: 0.97e1.50). Furthermore, chronological age was no longer significantly associated with all-cause, CVD or cancer mortality. Even when SES, BMI and smoking were included in the hazard models, biological age was found to be a strong predictor of all-cause, CVD and cancer mortality, while race remained nonsignificant. Finally, we examined the interaction between race and biological age and also ran race-stratified mortality models to determine whether the association between biological age and mortality differed for blacks and whites. Interactions between race and biological age were not statistically significant for any of the mortality outcomes. The stratified models also showed very little race differences across the three mortality outcomes. For instance, a one-year increase in biological age was associated with a 10% increase in all-cause mortality for whites, and an 8% increase in allcause mortality for blacks. For CVD, and cancer mortality, the risks for whites increased by 11% and 5%, respectively, with every one year increase in biological age, while the risks for blacks increased by 9% and 3%, respectively, with every one year increase in biological age.
Discussion
Our results suggest that being black is associated with significantly higher biological age and that this is a pathway to early death overall, and from CVD or cancer. We have long known that race is linked to earlier mortality and morbidity. Life expectancy at age 25 is about 5e6 years lower for U.S. Blacks than it is for whites (Arias, 2007) . Furthermore, disease incidence has also been found to occur significantly earlier for blacks (Bibbins-Domingo et al., 2009 ). However, this study is novel in offering evidence that racial differences in the pace of agingdas signified by biological agedmay be a central mechanism for the earlier overall and disease-specific mortality of black individuals.
Given that the physiological changes associated with the aging process lead to an increase in susceptibility to disease onset and death (Yin and Chen, 2005) , mortality and morbidity is likely to occur significantly earlier for individuals who are aging faster. Our results showed that on average blacks tend to be more than 3 years older biologically than whites. This is consistent with findings from previous studies reporting that blacks tend to have levels of biological risk factors that are indicative of someone significantly older chronologically (Geronimus et al., 2006) dproviding further evidence that the pace of aging may be accelerated.
Everyday stressors associated with being black may negatively impact physiological functioning and under chronic exposure, accumulate over the lifespan and contribute to growing disparities in biological risk. Furthermore, if such environmental, behavioral and mental factors contribute to an acceleration of the aging process, we would expect that persons who are aging the fastest should have the highest risk of mortality and thus be selected out of the population at younger ages due to their lower life expectancy. The presence of mortality selection should also lead to a convergence in biological risk between advantaged and disadvantaged populations (Vaupel and Yashin, 1985) . This is consistent with the current study, which showed that racial disparities in biological age systematically varied across the age range. We found that with increasing age, the gap in biological age between blacks and whites widened up until participants were nearing old age, after which point it began to converge. This suggests that the most disadvantaged blacks may be accumulating poorer and poorer health as they age; however, as those who are worst off are selected out of the population by mortality, disparities between blacks and whites steadily decrease. Similar findings have been shown when examining differences in indexes of biological risk by SES (Crimmins et al., 2009) .
We also showed that differences in biological age completely accounted for the increased risk of all-cause, CVD, and cancer Fig. 1 . Racial differences in adjusted mean biological age by 10-year chronological age groups. The difference in biological age between blacks and whites increased with chronological age prior to the age of 70. Blacks in their thirties, forties, fifties, and sixties had biological ages that were 2.28, 3.63, 4.59, and 4.82 years, respectively, higher than whites. However, for those in their seventies and eighties racial differences in biological age decreased to 2.94 and 1.17, respectively, and were no longer significant for persons ages 80e89. Models were adjusted for age, sex, education, BMI, and smoking. Bars represent stand errors of adjusted means. mortality experienced by blacks, thus implying that the black participants with the highest biological ages may also the one's contributing to the increased mortality risk among the black population. This is supported by our result showing no interaction between race and biological age. Higher biological age was associated with higher mortality risks among blacks and whites, suggesting that biological age operates similarly for both races. Finally, when comparing the mortality between blacks and whites who have equivalent biological ages, no significant differences are present.
While not a direct marker of mortality risk, the concept of biological age may do a good job estimating an individual's degree of physiological decline and dysregulation. Conventionally, cumulative risk scores or allostatic load have been used to examine disparities in physiological function (Geronimus et al., 2006 , Karlamangla et al., 2010 Merkin et al., 2009 ). However, racial differences in such measures have only been able to account for part of the association between race disparities in mortality (Duru et al., 2012) . Given that cumulative risk or allostatic load measures rely on counts of biomarkers for which a subject falls into a "high risk" category (Seeman et al., 2001) they may lose some of the information that could be gained from continuous measures (Levine and Crimmins, 2014) . For instance, aging-related breakdowns within various physiological systems tend to increase progressively over the lifespan, and as a result, race differences in the timing and age patterns of disease and mortality may be better explained by continuous measures that are more highly associated with the pace of biological aging.
Given that physiological declines associated with social inequalities are believed to accumulate and build over the life course, biological aging may be a useful measure for studying health disparities, particularly from a cumulative disadvantage framework. The theory of cumulative disadvantage describes how disadvantage, beginning in early life, or in prior generations, may intensify over time, leading to a divergence in health among various social groups (Merton, 1968) . While measures of allostatic load or cumulative risk based on clinical cut-points capture dysregulation after it has reached a critical point, they ignore the process of decline leading up to it, as well as the continuous progression of decline thereafter. From a life course perspective, measures of biological age may allow us to examine the shape of aging trajectories at different stages in life, to determine the role of early life or prenatal conditions, as well as the accumulation of disadvantage over time.
Additionally, differences in biological age could also reflect genetic differences between groups, or gene by environment interactions. For instance, populations with different ancestries may possess different frequencies of protective or risk alleles. As a result, biological age measures may serve as a useful phenotype for examining genetics of human aging. Additionally, it may also allow us to identify resilient personsdthose who appear biologically younger than expected. Ultimately, this could facilitate our ability to study how genetic or environmental factors enable some individuals to cope with disadvantage.
There are limitations in the present study that should be acknowledged. First, biomarker data for NHANES respondents were only available for a single time point, preventing us from looking at trajectories of biological age. Next, due to missing biomarker data, our analytic sample only included approximately 70% of NHANES participants ages 30e89 who were Non-Hispanic black or Non-Hispanic white. Overall those excluded from our analysis were 54% more likely to be black, 7 years older, had one less year of schooling and were 2.5 times as likely to die. As a result, our estimates of race differences are likely to be somewhat conservative. Table 3 Biological age mediates racial disparities in all-cause, CVD and cancer mortality (N ¼ 7587).
Hazard ratio (95% confidence interval) All-cause mortality CVD mortality The findings presented here provide evidence that blacks may be aging at a faster pace than whites and that biological aging is an important factor in explaining racial disparities in overall, CVD, and cancer mortality. In moving forward, the use of biological age may allow us to examine how social, behavioral, environmental, economic, and political factors contribute to health disparities, and how these disparities are affected by the accumulation of disadvantage over the life course.
